MBX vs. TH, SCYB, COM, NVH, IGX, ONC, COV, PDP, MDNA, and SVA
Should you be buying Microbix Biosystems stock or one of its competitors? The main competitors of Microbix Biosystems include Theratechnologies (TH), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), IntelGenx Technologies (IGX), Oncolytics Biotech (ONC), Covalon Technologies (COV), Pediapharm (PDP), Medicenna Therapeutics (MDNA), and Sernova (SVA). These companies are all part of the "biotechnology" industry.
Microbix Biosystems vs. Its Competitors
Theratechnologies (TSE:TH) and Microbix Biosystems (TSE:MBX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends.
Theratechnologies has a beta of 1.73, indicating that its share price is 73% more volatile than the S&P 500. Comparatively, Microbix Biosystems has a beta of 0.34, indicating that its share price is 66% less volatile than the S&P 500.
Microbix Biosystems has a net margin of 13.86% compared to Theratechnologies' net margin of -3.75%. Theratechnologies' return on equity of 14.30% beat Microbix Biosystems' return on equity.
In the previous week, Theratechnologies had 5 more articles in the media than Microbix Biosystems. MarketBeat recorded 5 mentions for Theratechnologies and 0 mentions for Microbix Biosystems. Theratechnologies' average media sentiment score of 0.02 beat Microbix Biosystems' score of 0.00 indicating that Theratechnologies is being referred to more favorably in the media.
51.2% of Theratechnologies shares are held by institutional investors. Comparatively, 0.4% of Microbix Biosystems shares are held by institutional investors. 1.2% of Theratechnologies shares are held by company insiders. Comparatively, 14.0% of Microbix Biosystems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Microbix Biosystems has lower revenue, but higher earnings than Theratechnologies. Theratechnologies is trading at a lower price-to-earnings ratio than Microbix Biosystems, indicating that it is currently the more affordable of the two stocks.
Summary
Theratechnologies beats Microbix Biosystems on 10 of the 15 factors compared between the two stocks.
Get Microbix Biosystems News Delivered to You Automatically
Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding MBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Microbix Biosystems Competitors List
Related Companies and Tools
This page (TSE:MBX) was last updated on 7/5/2025 by MarketBeat.com Staff
